| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919150 | Radiotherapy and Oncology | 2011 | 5 Pages |
Abstract
SBRT for stage I lung cancer is very well tolerated in this patient cohort with significant cardiopulmonal comorbidity and results in excellent local control rates, although a considerable portion develops regional and distant metastases.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Nicolaus Andratschke, Frank Zimmermann, Eva Boehm, Sabine Schill, Christine Schoenknecht, Reinhard Thamm, Michael Molls, Carsten Nieder, Hans Geinitz,